Ƶ

Twins and Dementia; CRISPR and Alzheimer's; BTK Inhibitor Fails in MS Trials

— News and commentary from the world of neurology and neuroscience

Ƶ MedicalToday
Neuro Break over a computer rendering of neurons.

Dementia in one twin of a co-twin without dementia. (Alzheimer's and Dementia)

Daily did not lead to overall cognitive function benefits compared with placebo, but subgroup analyses suggested possible benefits for people with poor diets. (American Journal of Clinical Nutrition)

CRISPR gene editing may open the door to for people whose Alzheimer's disease is associated with genetic variants. (Nature)

Sanofi ended its agreement to acquire an exclusive license for an investigational from Maze Therapeutics after the Federal Trade Commission issued a complaint.

Cortical lesions and the central vein sign helped increase (MS), an analysis by the MAGNIMS study group showed. (JAMA Neurology)

The investigational Bruton's tyrosine kinase (BTK) inhibitor in the phase III EVOLUTION trials of relapsing MS, Merck KGaA said.

Boston University experts are examining involved in the recent Lewiston, Maine, mass shooting for signs of potential trauma related to his service in the Army Reserves. (AP)

Statin use moderated APOE's and C-reactive protein's . (Alzheimer's and Dementia)

Photographs of a woman with dementia, her daughter said. (Washington Post)

The Washington Post also profiled who subsequently were diagnosed with chronic traumatic encephalopathy (CTE).

  • Judy George covers neurology and neuroscience news for Ƶ, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.